Richard B. Slansky
Director of Finance/CFO bij GENENTA SCIENCE S.P.A.
Vermogen: 251 790 $ op 31-03-2024
Profiel
Richard B.
Slansky currently works at Genenta Science SpA, as Chief Financial Officer from 2021.
Mr. Slansky also formerly worked at Quick Strike Resources, Inc., as Director, Chief Executive & Financial Officer from 2002 to 2003, Path 1 Network Technologies, Inc., as CFO, Secretary, VP-Administration & Operations from 2000 to 2002, SpaceDev, Inc., as President, Chief Financial Officer & Secretary, Star Equity Holdings, Inc., as Chief Financial Officer & Head-Investor Relations from 2010 to 2012, OncoSec Medical, Inc., as CFO, Secretary & Principal Accounting Officer, GenMark Diagnostics, Inc., as Chief Financial Officer from 2012 to 2014, and Biological Dynamics, Inc., as Chief Financial Officer.
Mr. Slansky received his Masters Business Admin degree from the University of Arizona and undergraduate degree from The Wharton School of the University of Pennsylvania.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
GENENTA SCIENCE SPA
0.39% | 19-04-2023 | 71 940 ( 0.39% ) | 251 790 $ | 31-03-2024 |
Actieve functies van Richard B. Slansky
| Bedrijven | Functie | Begin |
|---|---|---|
| GENENTA SCIENCE S.P.A. | Director of Finance/CFO | 20-05-2021 |
Eerdere bekende functies van Richard B. Slansky
| Bedrijven | Functie | Einde |
|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Director of Finance/CFO | 16-07-2018 |
| GENMARK DIAGNOSTICS, INC. | Director of Finance/CFO | 13-05-2014 |
| STAR EQUITY HOLDINGS, INC. | Director of Finance/CFO | 20-04-2012 |
SpaceDev, Inc.
 SpaceDev, Inc. Aerospace & DefenseElectronic Technology SpaceDev, Inc. develops spacecraft microsats, nanosats and maneuvering and orbital transfer vehicles. The company was founded by James Benson in 1997 and is headquartered in Sparks, NV. | Director of Finance/CFO | - |
| Quick Strike Resources, Inc. | President | 01-02-2003 |
Opleiding van Richard B. Slansky
| University of Arizona | Masters Business Admin |
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| STAR EQUITY HOLDINGS, INC. | Health Technology |
| ONCOSEC MEDICAL INCORPORATED | Health Services |
| GENENTA SCIENCE S.P.A. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Path 1 Network Technologies, Inc.
 Path 1 Network Technologies, Inc. Internet Software/ServicesTechnology Services Path 1 Network Technologies, Inc. offers internet protocol video transport products. It is the essential analytics and gateway provider for client IP video network, carrying the valuable content on the demanding networks throughout the world. The company was founded by Ronald D. Fellman and Douglas A. Palmer on January 30, 1998 and is headquartered in San Diego, CA. | Technology Services |
SpaceDev, Inc.
SpaceDev, Inc. Aerospace & DefenseElectronic Technology SpaceDev, Inc. develops spacecraft microsats, nanosats and maneuvering and orbital transfer vehicles. The company was founded by James Benson in 1997 and is headquartered in Sparks, NV. | Electronic Technology |
GenMark Diagnostics, Inc.
 GenMark Diagnostics, Inc. Medical SpecialtiesHealth Technology GenMark Diagnostics, Inc. engages in the development, manufacturing, sales, and support of instruments and molecular tests based on its proprietary eSensor detection technology. Its solutions include ePlex System and XT-8 System. The company was founded by Jon Faiz Kayyem in 1993 and is headquartered in Carlsbad, CA. | Health Technology |
| Quick Strike Resources, Inc. | |
Biological Dynamics, Inc.
 Biological Dynamics, Inc. Medical DistributorsDistribution Services Biological Dynamics, Inc. engages in the development of cancer diagnostic solutions for labs and homes. Its platform offers a way to isolate cell-free nanoparticles and macromolecules directly from whole blood, serum, or plasma. The firm also develops a suite of oncology tests for early cancer detection, treatment response, and recurrence monitoring. The company was founded by Raj Krishnan, Edward D. Truitt III, Michael J. Heller, Roy Lefkowitz, and David Charlot in 2008 and is headquartered in San Diego, CA. | Distribution Services |
